Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis

被引：122

作者：

Lazennec, G ^{[1
]}

机构：

[1] INSERM, U540, F-34090 Montpellier, France

来源：

CANCER LETTERS | 2006年 / 231卷 / 02期

关键词：

ovarian cancer; estrogen receptor; tumor-suppressor;

D O I：

10.1016/j.canlet.2005.01.021

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Ovarian cancer is one of the leading causes of death from gynecological tumors in women. Several lines of evidence Suggest that estrogens may play an important role in ovarian carcinogenesis, through their receptor, ER alpha and ER beta. Interestingly, malignant ovarian tumours Originating from epithelial Surface constitute about 90% of ovarian cancers and expressed low levels of ER beta, compared to normal tissues. In addition, restoration of ER beta in ovarian cancer cells, leads to strong inhibition of their proliferation and invasion, while apoptosis is enhanced. In this manuscript, recent data suggesting a possible tumour-suppressor role for ER beta in ovarian carcinogenesis are discussed. (c) 2005 Elsevier Ireland Ltd. All rights reserved.

引用

收藏

页码：151 / 157

页数：7

相关论文

共 78 条

[1] Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures - The Women's Health Initiative randomized trial [J].

Anderson, GL ;

Judd, HL ;

Kaunitz, AM ;

Barad, DH ;

Beresford, SAA ;

Pettinger, M ;

Liu, J ;

McNeeley, SG ;

Lopez, AM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (13) :1739-1748

[2]

Auwerx J, 1999, CELL, V97, P161

[3]

Bandera CA, 1997, CANCER RES, V57, P513

[4] RETRACTED: Involvement of estrogen receptor β in ovarian carcinogenesis (Retracted article. See vol 65, pg 5480, 2005) [J].

Bardin, A ;

Hoffmann, P ;

Boulle, N ;

Katsaros, D ;

Vignon, F ;

Pujol, P ;

Lazennec, G .

CANCER RESEARCH, 2004, 64 (16) :5861-5869

[5] Estrogen receptor alpha (ER-α) and beta (ER-β) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines:: Down-regulation of ER-β in neoplastic tissues [J].

Brandenberger, AW ;

Tee, MK ;

Jaffe, RB .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) :1025-1028

[6] Risk factors and risk reduction of breast and ovarian cancer [J].

Brekelmans, CTM .

CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2003, 15 (01) :63-68

[7] Estrogen receptor-beta mRNA expression in rat ovary: Down-regulation by gonadotropins [J].

Byers, M ;

Kuiper, GGJM ;

Gustafsson, JA ;

ParkSarge, OK .

MOLECULAR ENDOCRINOLOGY, 1997, 11 (02) :172-182

[8] A role for the androgen receptor in follicular atresia of estrogen receptor beta knockout mouse ovary [J].

Cheng, GJ ;

Zhang, WH ;

Mäkinen, S ;

Saji, S ;

Warner, M ;

Gustafsson, JÅ ;

Hovatta, O .

BIOLOGY OF REPRODUCTION, 2002, 66 (01) :77-84

[9] Expression of estrogen receptor β in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis [J].

Cheng, J ;

Lee, EJ ;

Madison, LD ;

Lazennec, G .

FEBS LETTERS, 2004, 566 (1-3) :169-172

[10] Estrogen receptor isoform gene expression in ovarian stromal and epithelial tumors [J].

Chu, S ;

Mamers, P ;

Burger, HG ;

Fuller, PJ .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03) :1200-1205

← 1 2 3 4 5 6 7 8 →